Bharat Parenterals Ltd - 541096 - Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results For The Quarter Ended 30Th June, 2021.
Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/08/2021 ,inter alia, to consider and approve 1. The unaudited financial results of the Company for the Quarter ended on June 30, 2021. Bharat Parenterals Ltd - 541096 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we bring to your kind attention that the Company/RTA has received a request from the shareholder regarding loss of her Share certificates. In this regard, Adroit Corporate Services Private Limited, RTA of company has verified the details and had informed the shareholder the necessary procedure for issue of duplicate share certificates. After receipt of valid documents the Share certificates will be issued within the statutory time limit. Bharat Parenterals Ltd - 541096 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we bring to your kind attention that the Company/RTA has received a request from the shareholder regarding loss of her Share certificates. In this regard, Adroit Corporate Services Private Limited, RTA of company has verified the details and had informed the shareholder the necessary procedure for issue of duplicate share certificates. After receipt of valid documents the Share certificates will be issued within the statutory time limit. Bharat Parenterals Ltd - 541096 - Shareholding for the Period Ended June 30, 2021
Bharat Parenterals Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here Bharat Parenterals Ltd - 541096 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on June 30, 2021. Bharat Parenterals Ltd - 541096 - Statement Of Investor Complaints For The Quarter Ended June 2021
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- LUBHANSHI JHALANIDesignation :- Company Secretary and Compliance Officer Bharat Parenterals Ltd - 541096 - Closure of Trading Window
The trading window for dealing in securities of the Company will be closed from July 01, 2021 and will remain closed till 48 hours after declaration of unaudited financial results of the Company for the first quarter ending on June 30, 2021. Bharat Parenterals Ltd - 541096 - Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Disclosure of Related Party Transactions pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 31.03.2021 Bharat Parenterals Ltd - 541096 - Disclosure Under Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Disclosure of Related Party Transactions pursuant to Regulation 23(9) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the half year ended 31.03.2021 Bharat Parenterals Ltd - 541096 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the financial year ended 31st March, 2021.